|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| @dpavot |
28294290 |
ME attenuated the influence of APOB rs512535 and TNFA rs361525 on obesity risk in FMP. |
86 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
| @dpavot |
28373572 |
The K+ channel KCNQ1 has been proposed as a tumor suppressor in colorectal cancer (CRC). |
99 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
| @dpavot |
28416184 |
Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating YAP/TAZ activity. |
109 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
| @dpavot |
28610954 |
A MMP9 inhibitor significantly inhibited cell invasion and migration in ALDOA-HIF-1α axis-induced lung cancer. |
110 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
| @dpavot |
28698647 |
FBXL4 potentially controls cancer metastasis through regulation of ERLEC1 levels. |
81 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
| @dpavot |
28768959 |
Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growt |
346 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
| @dpavot |
29103025 |
Further, we analyzed the expression of these nine genes during the progression of cervical cancer, and found that SPARCL1 is also related to precancerous lesions and migration processes during cervica |
222 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
| @dpavot |
29348457 |
By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and |
504 Bytes |
2020-02-26 |
|
2 |
|
6 |
-
|
| @dpavot |
29376860 |
As an important multifunctional protein involved in regulation of mitochondrial metabolism, CHCHD2 was identified as a causative gene for Parkinson's disease (PD), yet the relationship between CHCHD2 |
254 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
| @dpavot |
29499401 |
Functional assays indicate that SPINT2 reactivation ameliorates the malignant phenotype, specifically reducing cell viability, migration and invasion in diverse cancer cell lines. |
179 Bytes |
2020-02-26 |
|
1 |
|
3 |
-
|
